User profiles for E. Stalika

evangelia stalika

International Hellenic University
Verified email at bua.teithe.gr
Cited by 1461

Recurrent mutations refine prognosis in chronic lymphocytic leukemia

…, A Agathangelidis, Z Davis, E Tausch, E Stalika… - Leukemia, 2015 - nature.com
Through the European Research Initiative on chronic lymphocytic leukemia (CLL)(ERIC),
we screened 3490 patients with CLL for mutations within the NOTCH1 (n= 3334), SF3B1 (n= …

Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact

…, J Delgado, F Baran-Marszak, E Stalika… - Blood, The Journal …, 2019 - ashpublications.org
Recent evidence suggests that complex karyotype (CK) defined by the presence of ≥3
chromosomal aberrations (structural and/or numerical) identified by using chromosome-banding …

Distinct patterns of novel gene mutations in poor-prognostic stereotyped subsets of chronic lymphocytic leukemia: the case of SF3B1 and subset# 2

…, J Malčíková, K Plevová, L Scarfó, Z Davis, E Stalika… - Leukemia, 2013 - nature.com
Recent studies have revealed recurrent mutations of the NOTCH1, SF3B1 and BIRC3 genes
in chronic lymphocytic leukemia (CLL), especially among aggressive, chemorefractory …

[HTML][HTML] Different spectra of recurrent gene mutations in subsets of chronic lymphocytic leukemia harboring stereotyped B-cell receptors

…, K Plevova, D Rossi, J Kminkova, E Stalika… - …, 2016 - ncbi.nlm.nih.gov
We report on markedly different frequencies of genetic lesions within subsets of chronic
lymphocytic leukemia patients carrying mutated or unmutated stereotyped B-cell receptor …

Clonal B-cell lymphocytosis exhibiting immunophenotypic features consistent with a marginal-zone origin: is this a distinct entity?

…, S Mould, Z Davis, E Stalika… - Blood, The Journal …, 2014 - ashpublications.org
The biological and clinical significance of a clonal B-cell lymphocytosis with an
immunophenotype consistent with marginal-zone origin (CBL-MZ) is poorly understood. We …

Restrictions in the T-cell repertoire of chronic lymphocytic leukemia: high-throughput immunoprofiling supports selection by shared antigenic elements

A Vardi, E Vlachonikola, M Karypidou, E Stalika… - Leukemia, 2017 - nature.com
Immunoglobulin (IG) gene repertoire restrictions strongly support antigen selection in the
pathogenesis of chronic lymphocytic leukemia (CLL). Given the emerging multifarious …

[HTML][HTML] Tailored approaches grounded on immunogenetic features for refined prognostication in chronic lymphocytic leukemia

…, N Villamor, H Parker, J Kotaskova, E Stalika… - …, 2019 - ncbi.nlm.nih.gov
Chronic lymphocytic leukemia (CLL) patients with differential somatic hypermutation status
of the immunoglobulin heavy variable genes, namely mutated or unmutated, display …

Antigen selection shapes the T-cell repertoire in chronic lymphocytic leukemia

A Vardi, A Agathangelidis, E Stalika, M Karypidou… - Clinical Cancer …, 2016 - AACR
Purpose: The role of antigen(s) in shaping the T-cell repertoire in chronic lymphocytic leukemia,
although relevant for understanding malignant cell interactions with cognate T cells, is …

[HTML][HTML] SBA-15 mesoporous silica as delivery vehicle for rhBMP-2 bone morphogenic protein for dental applications

…, GK Pouroutzidou, E Christodoulou, E Stalika… - Nanomaterials, 2022 - mdpi.com
(1) Background: A proposed approach to promote periodontal tissue regeneration in cases of
peri-implantitis is the local administration of growth factors at the implant site. Recombinant …

[HTML][HTML] Karyotypic complexity rather than chromosome 8 abnormalities aggravates the outcome of chronic lymphocytic leukemia patients with TP53 aberrations

…, A Anagnostopoulos, E Gimeno, E Abella, E Stalika… - Oncotarget, 2016 - ncbi.nlm.nih.gov
Patients with chronic lymphocytic leukemia (CLL) harboring TP53 aberrations (TP53abs;
chromosome 17p deletion and/or TP53 mutation) exhibit an unfavorable clinical outcome. …